The goal of this project is to define the functional role of carbohydrate in the antibody molecule. We will address two fundamental questions: Firstly, we will determine how the structure of the carbohydrate attached to the variable and/or the constant region of the antibody molecule influences its functional properties. Secondly, we will attach carbohydrate to different positions in the variable region to define the mechanism by which the presence of V region carbohydrate influence antigen- antibody interactions; we will also determine if V region carbohydrate facilitates the purification of antibodies using lectins, and influences the biochemical properties of the antibody. To investigate the role of the variable region carbohydrate we will use anti-dextran antibodies in which it has been demonstrated that the presence of carbohydrate at residue 58 in CDR2 of the VH region leads to increased affinity for antigen and is available for lectin binding. We will place carbohydrate at different positions in the variable region using site directed mutagenesis coupled with transfection and expression into murine myeloma cell lines or Chinese hamster ovary cells. Carbohydrate will be positioned at exposed sites proximal and distal to residue 58. It will be ascertained whether the carbohydrate addition site is utilized, the effect of carbohydrate on antigen binding, and accessibility of the carbohydrate to binding by lectins. To assess the influence of carbohydrate structure on antibody function, we will use gene transfection techniques to produce antibodies in Chinese hamster ovary cells with different mutations in the N-linked glycosylation pathway. The antibodies produced will be evaluated with respect to their ability to bind their specific antigen, with respect to their effector functions such as complement activation and receptor binding and with respect to their biochemical and biologic properties such as serum half- life, ability to form immune complexes, and tendency to self-aggregate. These studies will define the influence of the carbohydrate structure on the functional properties of the antibody molecules. It will contribute to our understanding of how antibodies function and how abnormal function can contribute to disease. In addition, as more and more antibody molecules are produced using expression systems, it is important that we understand what carbohydrate structures are required for different functional properties so that the correct expression system can be utilized. Also, since some expression systems can change their glycosylation patterns, it is important that we understand the impact of alternated carbohydrate structures on the functional properties of the antibody molecule so that proper quality controls can be maintained during production.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI029470-05
Application #
2065004
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1990-12-01
Project End
1996-03-31
Budget Start
1994-12-01
Budget End
1996-03-31
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Microbiology/Immun/Virology
Type
Schools of Arts and Sciences
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kim, Yun Cheol (2011) Introducing predetermined mutations throughout a target gene using TDEM (transposon-directed base-exchange mutagenesis). Methods Mol Biol 705:275-93
Yoo, Esther M; Yu, Li J; Wims, Letitia A et al. (2010) Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines. MAbs 2:320-34
Kim, Yun Cheol; Lee, Hui Sun; Yoon, Sukjoon et al. (2009) Transposon-directed base-exchange mutagenesis (TDEM): a novel method for multiple-nucleotide substitutions within a target gene. Biotechniques 46:534-42
Chintalacharuvu, Koteswara R; Gurbaxani, Brian; Morrison, Sherie L (2007) Incomplete assembly of IgA2m(2) in Chinese hamster ovary cells. Mol Immunol 44:3445-52
Beenhouwer, David O; Yoo, Esther M; Lai, Chun-Wei et al. (2007) Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infect Immun 75:1424-35
Gurbaxani, Brian Mohan; Morrison, Sherie L (2006) Development of new models for the analysis of Fc-FcRn interactions. Mol Immunol 43:1379-89
Dela Cruz, Jay Soriano; Trinh, Kamh Ryan; Chen, Hsiao Wen et al. (2006) Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: implications in immunotherapy and vaccination strategies. Mol Immunol 43:667-76
Helguera, Gustavo; Dela Cruz, Jay S; Lowe, Christine et al. (2006) Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors. Vaccine 24:304-16
Gurbaxani, Brian; Dela Cruz, Linh L; Chintalacharuvu, Koteswara et al. (2006) Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life. Mol Immunol 43:1462-73
Zhu, Lei; van de Lavoir, Marie-Cecile; Albanese, Jenny et al. (2005) Production of human monoclonal antibody in eggs of chimeric chickens. Nat Biotechnol 23:1159-69

Showing the most recent 10 out of 70 publications